Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How the ACR Helps with Reimbursement, Utilization Management & Other Practice Challenges

Carina Stanton  |  Issue: October 2024  |  September 6, 2024

Connecting with Your Practice Advocacy Team

“ACR members are our best source of information about the insurance-related challenges facing rheumatology practices,” Ms. Strozier reiterates.

Specifically, ACR practice staff and members of the ISC want to hear from practices about their experiences with such payer issues as denials, coverage changes, step therapy requirements, prior authorizations, programs limiting use copay assistance funds and more. Report an issue by completing ACR’s online health plan complaint form or emailing [email protected]. 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“If you have difficulty with a patient not being able to get medically necessary therapy and for any reason are unable to get it due to illogical insurance practices, or if reimbursements are not being given for services in a reasonable manner, do not hesitate to contact the ACR’s insurance advocacy team,” Dr. Thomas says.


Carina Stanton is a freelance science journalist based in Denver.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:InsurancePractice ManagementPractice Support Tagged with:ACR advocacyACR Insurance Subcommittee (ISC)Member benefits

Related Articles

    ACR Insurance Subcommittee Chair Encourages Member Engagement

    January 20, 2022

    Rheumatology practices have a voice in payer advocacy through the Insurance Subcommittee of the ACR’s Committee on Rheumatologic Care.

    New Wins, Ongoing Challenges for ACR Insurance Subcommittee

    July 3, 2019

    Corrections to reimbursement system errors with Aetna and a Medicare contractor demonstrate the latest wins for all providers by the ACR’s Insurance Subcommittee. But the committee remains hard at work advocating for rheumatologists on several fronts.

    Protect Your Practice: Action Update From the ACR’s Insurance Subcommittee

    November 5, 2018

    Both private and academic rheumatology practices face payer challenges that put the health of their patients and their practices at risk. To make sure the rheumatologist perspective is heard by payers, “the ACR’s Insurance Subcommittee (ISC) serves as the interface between payers and our members and ACR colleagues,” explains Sean Fahey, MD, a rheumatologist in…

    Updates from the ACR Insurance Subcommittee

    March 7, 2024

    The Insurance Subcommittee is working to address coverage and reimbursement challenges facing rheumatology practices, including issues related to biosimilar use, in-office treatments and the new G2211 code.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences